The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review
Three (13.6%) of the patients with squamous cell carcinoma had pre-medication with ACE inhibitors, 3 (13.6%) had pre-medication with HCT, and 2 (9.1%) of the patients were taking both drugs
As GLP-1 adjuvants, MC4R-selective agonists are positioned as valuable therapeutics for both general and genetic obesity
Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al
no extra precautions are needed
The main limitation of our meta-analysis is the small number of studies (together with small sample sizes) currently in the literature, with single studies only for the posterior cingulate cortex, the hippocampus, and the thalamus (none of which showed a difference in GSH levels between cases and controls)